$HIPH -News PR! $0.15 target by See ThruEquity !! See full

New Post Public Reply Private Reply Replies (0) Message Board
stockstein
81
$HIPH -News PR! $0.15 target by See ThruEquity !! See full report on www.seethruequity.com/news/ . Overview of report & press release out by See ThruEquity on Accesswire. Good research DD. In my opinion $HIPH very undervalued currently.



NEW YORK, NY / ACCESSWIRE / June 21, 2018 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has initiated coverage on American Premium Water Corp. (OTC PINK: HIPH) with a Target Price of $0.15.

The report is available here: June 2018 Initiation Report.

We initiate coverage on American Premium Water Corp. (OTC PINK: HIPH, $0.020) with a price target of $0.15. HIPH is a diversified company focused on premium consumer brands and products. It currently sells and markets hydrogen-infused water under the LALPINATM brand and luxury apparel under the Gents brand. We expect HIPH growth to be supported by two commercial initiatives planned for this year: Hydrogen-infused Water and Hydrogen CBD-infused Water. Both product lines have high potential given: 1) the rising consumer interest in legal CBD products; and 2) the large and expanding market for functional water. LALPINATM Hydrogen is already selling via select channels, and the company is planning for a full-scale launch in the coming quarters. The company debuted LALPINATM Hydrogen CBD in January 2018, and it is expected to be launched in June 2018. The functional bottled water market in the US is expected to reach ~$2.9 billion by 2020 driven by a shift in consumer preference from soda-based to more nutritional and healthier drinks. This is evident from the rising demand of seltzer water, ionized water and smart water, among others. Hydrogen-infused water has the potential to become a new category in this trend. HIPH has an early mover advantage in the hydrogen infused water market which currently has limited competition.

LALPINA Hydrogen CBD positions the company to tap into growing consumer interest around CBD related products as this is the only known Hydrogen CBD water in the market. There is a large market opportunity given the growing number of cannabis dispensaries which could be potential customers.

We are also intrigued by management's effort to position Gents as an emerging luxury apparel brand. The recent acquisition of Worthy, a JV with China-based Zhangjiagang Advanced Company (ZAC), and collaborations with Showtime and SoulCycle should help expand footprint and consumer reach. HIPH has also entered the fast growing blockchain space via the acquisition of FashionCoinX, which further diversifies its potential revenue streams. HIPH noted a number of acquisition opportunities in the pipeline - all of which could further support growth. Going forward, we expect HIPH to increase revenues and earnings via new product launches, aggressive distribution and marketing, entry into new regions and M&A.

Well positioned as a luxury consumer lifestyle brand

HIPH manufactures and distributes consumer products under the LALPINATM and Gents brands. The LALPINATM brand focuses on hydrogen infused bottled water via its two products: LALPINATM Hydrogen (launched in 1Q18) and LALPINATM Hydrogen CBD (to be launched in June 2018). The bottled water market with functional benefits such as added alkalinity, electrolytes, vitamins, minerals is seeing significant traction among consumers. The shift in consumer preference to healthier and nutritional drinks is likely to further drive the growth of functional water market. The functional bottled water market in the US is expected to reach ~$2.9 billion by 2020. HIPH has an early mover advantage in the hydrogen infused water market which currently has limited competition. LALPINATM Hydrogen CBD is a front runner in the space as the only known hydrogen infused CBD beverage available on the market. The primary competitive advantage is that it improves bioavailability of CBD and absorption. The CBD market could reach $2.1 billion by 2020, according to Hemp Business Journal.

Gents is a producer of luxury hats and other fine accessories and apparel. Presence in 200 retail outlets internationally including upscale names such as Bloomingdale's, Nordstrom, and Saks Fifth Avenue strengthens its positions as a luxury brand. The acquisition of New York-based streetwear brand, Worthy further diversifies the apparel revenue stream. It will expand the price points offered by Gents and opens up many new distribution channels.

Expansion in blockchain/crypto space

The recent acquisition of FashionCoinX marks HIPH's entry in the fast growing blockchain/crypto space. Blockchain is one of the fastest growing technologies and entry in the space should benefit HIPH. According to Market Reports Center, the size of the blockchain industry will grow to $60.7 billion by the year 2024. HIPH is looking for more opportunities in the blockchain/crypto space that will complement its existing LALPINATM and Gents brands.

Aggressive marketing push to drive topline

HIPH plans to enter into partnerships and collaborations to increase distribution and marketing reach. The JV with China-based Zhangjiagang Advanced Company and collaborations with Showtime drama 'Billions' and fitness chain SoulCycle should help expand Gents footprint and consumer reach. Further, LALPINA's distribution agreement with GNC, one of the world's largest vendors of health and nutritional products, is likely to result in strong order flow. The management noted that it is working on several more distribution partnerships for both brands which should further bolster the topline.

Initiate coverage with a price target of $0.15

We see HIPH as a high risk and high reward consumer brand play. The target of $0.15 assumes that the company is successful in executing its organic and inorganic growth revolving around product expansion, strategic partnerships and M&A. Key risks include inability to raise capital for its growth initiatives and delay in the launch of LALPINATM Hydrogen CBD.

Please review important disclosures in the report and on our website at www.seethruequity.com.

About American Premium Water Corp.

HIPH is a manufacturer, distributor, and marketer of branded consumer products. It currently markets and distributes products under LALPINATM and Gents brands. Under the LALPINATM brand, the company develops hydrogen-infused energy products. Currently, the product line includes - 1) LALPINATM Hydrogen and 2) LALPINATM Hydrogen CBD. Gents is a producer of luxury hats and other fine accessories and apparel. The brand is carried in over 200 retail outlets internationally, including Bloomingdale's, Nordstrom, and Saks Fifth Avenue, among other boutiques and upscale retailers. For more information, visit www.americanpremiumwater.com

About SeeThruEquity

Since its founding in 2011, SeeThruEquity has been committed to its core mission: providing impactful, high quality research on underfollowed smallcap and microcap equities. SeeThruEquity has pioneered an innovative approach to deliver equity research of microcap and smallcap companies. SeeThruEquity has also been the host of acclaimed investor conferences that are the ultimate event for publicly traded companies with market capitalizations less than $1 billion since 2012.

SeeThruEquity is approved to contribute its research reports and estimates to Thomson One Analytics (First Call), the leading estimates platform on Wall Street, as well as Capital IQ and FactSet. SeeThruEquity maintains one of the industry's most extensive databases of opt-in institutional and high net worth investors. The firm is headquartered in Midtown Manhattan in New York City.

For more information visit www.seethruequity.com.

Contact:

SeeThruEquity
info@seethruequity.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 188

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 296

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 319

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 240

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 283

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 462

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 597

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 235

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 81

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 246

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading

Top 5 Most Recently Viewed Articles

New Partnership Expands Eco-Friendly Solutions in the South

Updated Category News Views 234

Expanding Environmental Solutions in the Southern States Easy Environmental Solutions Inc., formerly known as Digital Utilities Ventures, is excited to announce a significant partnership with Organic Living Soil, LLC. As the exclusive dealer for Easy Environmental Solutions in Louisiana and Mississippi, Organic Living Soil aims to revolutionize the way eco-friendly...

Continue Reading
Michael Young Enhances Ty J. Young Wealth Management Team

Updated Category News Views 244

Michael Young Joins Ty J. Young Wealth Management Ty J. Young Wealth Management, a prominent name in financial services, proudly announces the appointment of Michael Young as Vice President of Business Development. With a wealth of experience from his previous role as a sales executive in a Fortune 500 company, Young is set to take the lead in expanding the firm's...

Continue Reading
Johnson & Johnson Advances Myeloma Treatment with FDA Application

Updated Category News Views 289

Johnson & Johnson took a big swing back in 2024 when they submitted a supplemental Biologics License Application (sBLA) for their myeloma treatment, DARZALEX FASPRO®. This move aimed at getting the green light from the FDA for use among newly diagnosed multiple myeloma patients who couldn't go through autologous stem cell transplants. Desks buzzed with chatter on how...

Continue Reading
What Investors Should Anticipate in ScanSource's Earnings Report

Updated Category News Views 121

ScanSource's Earnings Report: Expectations and Insights ScanSource (NASDAQ:SCSC) is gearing up to release its quarterly earnings report soon. Investors are particularly interested in the results that are expected to be announced shortly. With the anticipation building, understanding what to look for is essential. Predicted Earnings Results Industry experts have estimated...

Continue Reading
Revealing the Truth: IRS Data Access by Immigration Authorities

Updated Category News Views 127

IRS Data Accessed by Immigration Authorities: An Overview Federal immigration officials gained access to taxpayer information from the IRS during the previous administration's deportation efforts, though they claim this data was not used to identify individuals for removal. This raises serious questions surrounding privacy and immigration enforcement. Cross-Referencing...

Continue Reading